Dosing Information Adult: In Angina pectoris, chronic, initial, 500 mg orally twice daily; increase to the maximum recommended dose of 1000 mg orally twice daily as needed based on clinical symptoms. Pediatric: Safety and efficacy not established in pediatric patients. Contraindications • Concurrent use of potent and moderately potent CYP3A inhibitors, including diltiazem, verapamil, macrolide antibiotics, HIV protease inhibitors, ketoconazole and other azole antifungals, and grapefruit juice or grapefruit-containing products; increased ranolazine levels and QTc prolongation. • Concurrent use of QT prolonging drugs (such as Class Ia and Class III antiarrhythmics, and certain antipsychotic). • Hepatic impairment, Child-Pugh Classes A, B or C; QTc prolongation is increased approximately 3-fold. • QT prolongation, pre-existing, including congenital long QT syndrome and uncorrected hypokalemia. Precautions • Concurrent use of CYP3A and P-glycoprotein inducers (eg, carbamazepine, phenobarbi...